Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a comprehensive review, Fortune has identified the best CBD oils for 2024, catering to various health needs. The article highlights top picks for pain relief, anxiety management, and sleep improvement, based on factors such as CBD type, dosage, and third-party testing. Canna River’s CBD Ultra Pain Tincture leads for pain management, while Charlotte’s Web
READ MOREIn a groundbreaking move, President Biden has endorsed the reclassification of cannabis, signaling a significant change in U.S. drug policy. The administration is urging federal regulators to move marijuana from Schedule I to Schedule III of the Controlled Substances Act, a change that would acknowledge its medical value and reduce criminal penalties associated with its
READ MORECBD oil, once a fringe product, has surged into the mainstream Australian medical landscape, offering potential benefits for various health conditions. This non-psychoactive cannabis derivative is gaining traction for its diverse applications, from pain relief to mental health support. While CBD oil became legal in Australia in 2015, strict regulations have made it challenging to
READ MOREIn a world-first initiative, Victoria is set to begin a trial allowing medicinal cannabis patients to drive on closed roads. The Victorian government aims to research the impact of cannabis on driving impairment, potentially paving the way for legal reforms. Starting in September, about 70 participants will drive at special facilities under instructor supervision. The
READ MOREGeorgia is set to implement new regulations on its burgeoning hemp industry, aiming to cap the amount of delta-9 THC in various cannabis products. The law, effective October 1, introduces strict limits on THC content in gummies, beverages, topicals, and tinctures. For instance, gummies cannot exceed 10mg of delta-9 THC per serving, while beverages are
READ MOREA groundbreaking clinical trial in Australia is exploring the potential of a new CBD-based capsule to combat insomnia. Conducted by Melbourne biotech company Avecho, the trial seeks to recruit 519 participants suffering from episodic insomnia—sleep disturbances lasting one to three months. The capsule, taken once daily before bed, contains cannabidiol (CBD), a compound known for
READ MORE